Adagene inc.

Major-Pharmaceuticals

ADAG


Executive/
Director

Price

  • Last Close
  • $ 2.16
    $ +0.01 0.47 %
    Dec 6, 2024
  • 52-Week High/Low
  • $4.15 - $1.25
  • YTD
  • 12.5%

  • Trading Volume
  • 100
  • Market Cap Full
  • $ 116.8M
  • Shares Outstanding
  • 54.1M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -56.7% 6.8% 46.9%
Q2 - - - - - - -24.5% -41% 0.7% -4.2%
Q3 - - - - - - 5.9% -38% 1.4% -
Q4 - - - - - - -43.8% 3.1% 34.3% -
J F M A M J J A S O N D
2024 90.6% -13.4% -11% 6.4% - - - - - - - -
2023 45.5% -6.3% -21.7% -4.3% -0.7% 6% -4.2% 5.9% - -4.2% 17.4% 18.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-84%45%13%

Earnings

2018 2019 2020 2021 2022 2023
Q1 - - - - - -
Q2 - - - - - -
Q3 - - - - - -
Q4 - - - - - -
A -0.9 -1.1 -2.7 -1.5 -1.5 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022
Mar - - -
Jun - - -
Sep - - -
Dec 43.9 54.6 54.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 3 3.3 0.2 - -
Total Asset Turnover 0.1 0.1 - - -
Leverage
Debt Ratio 0.1 - - - -
Debt – Equity Ratio 0.2 - - - -
Interest Coverage 21 -72 43 6.3 -
Equity multiplier - - -0.1 - -